Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
46 hedge funds and large institutions have $29.6M invested in Psychemedics Corporation in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 9 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
12% less funds holding
Funds holding: 52 → 46 (-6)
34% less capital invested
Capital invested by funds: $44.5M → $29.6M (-$15M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.3M |
| 2 |
BlackRock
New York
|
+$813K |
| 3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$198K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$157K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$152K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MRCM
51
Mill Road Capital Management
Greenwich,
Connecticut
| – | -$209K | -14,896 | Closed |
|
|
AIM
52
Alambic Investment Management
Belvedere,
California
| – | -$163K | -11,636 | Closed |
|
|
AG
53
Advisor Group
Phoenix,
Arizona
| – | -$4K | -300 | Closed |
|
54
Bank of America
Charlotte,
North Carolina
| – | -$1K | -40 | Closed |
|
PMD Hedge Fund Activity: Q2 2019 in Review
46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2019, worth a combined $29.6M — down 34% from $44.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PMD and 3 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 17 added.
The largest buyer was Kennedy Capital Management, adding an estimated $2.3M. The largest seller was Wellington Management Group, exiting entirely with an estimated $3.93M sold.
- 46 institutional investors held Psychemedics Corporation (PMD) as of Q2 2019, down from 52 in Q1 2019.
- Funds reported $29.6M of Psychemedics Corporation stock for Q2 2019, down 34% quarter-over-quarter.
- 3 funds opened new Psychemedics Corporation positions in Q2 2019 and 9 closed out, a net change of -6 holders.
- The largest Psychemedics Corporation buyer in Q2 2019 was Kennedy Capital Management, an estimated $2.3M added.
- The largest Psychemedics Corporation seller in Q2 2019 was Wellington Management Group, an estimated $3.93M sold.
Based on aggregated 13F filings for Q2 2019.